This Week’s Marijuana/ Hemp Stocks
Added; $ADVT, $CHIF, $ESSI
Also added in
Marijuana/Cannabis/Hemp: $GLAG, $NEWC, $MYHI, $SIPC, $VAPE
Biotech, Renewables, Tech & Defense Stocks also added to Investor
Directories
Point Roberts, WA, Delta BC – February 10, 2017 –
Investorideas.com, a global news source and investor resource covering actively
traded sectors announces this week’s additions to its investor membership, including global stock directories in marijuana, biotech, renewables,
tech and defense.
Investorideas.com tracks companies in high profile
trading sectors and makes ongoing additions to its stock directories for each
sector. Listing for the stock directories include companies on the
TSX, OTC, NYSE, NASDAQ and global stock exchanges.
Marijuana/Hemp companies added are involved in
medical marijuana, a marijuana tech company, commercial hemp, CBD products,
vaporization products and a company that provides a hemp infused beer called ‘Major
Hemp Brown Ale’.
Biotech companies include Coherent, Inc. (NasdaqGS:COHR), one of the world’s leading providers of lasers,
laser-based technologies and laser-based system solutions. This company has also crossed over into our tech,
defense and renewable (solar) stock lists. (see below).
Other biotech
additions include companies involved in ophthalmology,
including one that is helping people with visual prosthetics for the
blind. Also added are companies providing
for patients suffering from PTSD, cancer and post surgical pain.
Our latest tech additions include the previously
mentioned Coherent, Inc.
(NasdaqGS:COHR), along with the
Marijuana/Hemp listed stock Eco Science Solutions, Inc. (OTC:ESSI) which provide enterprise software to the
alternative medicine and health and wellness sectors. The company’s services also include localized communications between
consumers and business operators, social networking with like-minded
enthusiasts, rich educational content, e-commerce, and rapid delivery of products.
The newest defense companies include, along with Coherent, Inc. (NasdaqGS:COHR), Wesco Aircraft Holdings, Inc. (NYSE:WAIR), the
world’s leading distributor and provider of comprehensive supply chain
management services to the global aerospace industry.
New Marijuana
Companies Added:
Advantis Corp (OTC:ADVT) develops products and works with developing companies to provide
innovative healthcare products, holistic pain management solutions, and enhance
the footprint in the evolving legal cannabis business. Advantis acquires
ownership in developing companies that work within the nutraceutical and the
alternative health care industries; consulting with these organizations to
improve their product lines, expand their distribution channels through
internal partnership agreements, and heighten brand value.
China Food & Beverage Company (OTC:CHIF) is a U.S. holding company
whose strategy is the acquisition of companies in the medical cannabis
industry, as well as the formation of joint venture partnerships and strategic
alliances.
Eco Science Solutions, Inc. (OTC:ESSI) is a
technology-focused Company based in Hawaii, targeting the multibillion-dollar
health, wellness and alternative medicine industry. From enterprise software,
to consumer applications for daily use, the Company develops technical
solutions that empower enthusiasts in their pursuit and enjoyment of building
eco-friendly businesses and living healthy lifestyles. Eco Science's core
services span localized communications between consumers and business
operators, social networking with like-minded enthusiasts, rich educational
content, e-commerce, and rapid delivery of products, all catering to the
health-and-wellness lifestyle.
Gala Global Inc (OTC:GLAG) is a publicly-traded company focused on the development and
commercialization of cannabis derived products. The company is developing
relationships with numerous groups within the cannabis and hemp industry as
well as Indian Tribes looking to take advantage of the newly given
opportunities by the federal government regarding cannabis on tribal lands. We
are still in the process of developing a hemp fiber clothing line and a
therapy line of nutraceutical CBD products. Gala Global, Inc., professional
services group provides operational services and technologies that drive
efficiencies in the medical and recreational cannabis market.
New Colombia Resources Inc (OTC:NEWC) is a two-pronged company with not only premium
coking coal but medical marijuana operations, two of the hottest sectors in
today's market. The Company has a joint venture in Colombia, Sannabis, producing
medical marijuana products since 2014. New Colombia has hired a production
company in Miami and teamed up with a retired World Series MVP to begin
marketing some of these products in the U.S. where legal.
Mountain High Acquisitions Corp (OTC:MYHI) is a holding company focused on the commercial hemp and CBD products
industries. Our first acquisition in
this sector is GreenLife BotaniX, Inc.
Sipp
Industries Inc (OTC:SIPC) is a multifaceted corporation that specializes in
technology, manufacturing and distribution of commercial and consumer products.
Through its wholly owned subsidiary, Major Hemp, the Company provides high
quality and competitively priced hemp based products, bulk hemp, CBD supply,
co-packing and private labeling services, including “Major Hemp Brown Ale”
brewed by Sleeping Giant Brewing of Colorado’
Vape Holdings Inc (OTC:VAPE) focuses on designing, marketing, and distributing various vaporization
products. The company offers medical and food grade ceramic products primarily
under the HIVE Ceramics brand throughout North America, Europe and South
America. HIVE offers a nonporous, non-corrosive, chemically inert ceramic
vaporization element, which can be used for a range of applications, including
stand-alone vaporization products and electronic cigarettes. The company is
based in Agoura Hills, California.
New Biotech
Companies Added:
Coherent, Inc. (NasdaqGS:COHR) is one of the world's leading providers of lasers,
laser-based technologies and laser-based system solutions for scientific,
commercial and industrial customers. Our common stock is listed on the Nasdaq
Global Select Market and is part of the Russell 2000 and Standard & Poor's
SmallCap 600 Index. Biotech
Presbia PLC (NasdaqGM: LENS) is an ophthalmic device company that has
developed and is currently marketing the presbyopia-correcting Presbia Flexivue
Microlens™, a miniature lens that is implanted in a corneal pocket created by a
femtosecond laser. The Presbia Flexivue Microlens™ has received a CE mark for
the European Economic Area, allowing the lens to be marketed in over 30
countries across Europe. A staged pivotal U.S. clinical trial for the Presbia
Flexivue Microlens™ commenced in 2014.
Second Sight Medical Products, Inc. (NasdaqCM:
EYES) mission is to develop, manufacture and
market innovative implantable visual prosthetics to enable blind individuals to
achieve greater independence. Second Sight has developed and manufactures the
Argus II Retinal Prosthesis System. Second Sight is currently underway in a
trial to test the safety and utility of the Argus II in individuals with Dry
Age-Related Macular Degeneration. Second Sight is also developing the Orion™ |
Visual Cortical Prosthesis to restore some vision to individuals who are blind
due to causes other than preventable or treatable conditions. U.S. Headquarters
are in Sylmar, California, and European Headquarters are in Lausanne,
Switzerland.
Recro Pharma, Inc. (NasdaqCM:
REPH) is a revenue-generating, specialty pharmaceutical
company primarily focused on developing innovative products for hospitals and
ambulatory care settings. The Company’s lead product candidate, injectable
meloxicam, is a proprietary injectable form of meloxicam, a long-acting
preferential COX-2 inhibitor that has successfully completed four Phase II
clinical trials in the treatment of moderate to severe postoperative pain, and
two pivotal Phase III clinical trials in patients following bunionectomy and
abdominoplasty surgeries. As injectable meloxicam is not in the opioid class of
drugs, the Company believes it will overcome many of the issues associated with
commonly prescribed opioid therapeutics, including addiction, misuse\diversion,
respiratory distress and constipation while maintaining analgesic, or pain
relieving, effect. In addition to developing
proprietary drug candidates, Recro, through its subsidiary, Recro Gainesville
LLC, leverages its formulation expertise to develop and manufacture
pharmaceutical products using its proprietary delivery technologies for
commercial partners who commercialize or plan to commercialize these products.
These collaborations result in revenue streams including royalties, profit
sharing, research and development and manufacturing, which support continued
operations for Recro Gainesville as well as the Company’s research and
development of proprietary product candidates.
Tonix Pharmaceuticals Holding Corp. (NasdaqGM:
TNXP) is developing innovative pharmaceutical
products to address current and emerging public health challenges, with two
programs focusing on PTSD. TNX-102 SL is ready to start Phase 3 clinical trials
and TNX-601 is in pre-IND stage of development. PTSD is a serious condition
characterized by chronic disability, inadequate treatment options especially
for military-related PTSD and overall high utilization of healthcare services
creating significant economic burden. TNX-102 SL was recently granted
Breakthrough Therapy designation by the FDA for the treatment of PTSD. Other
development efforts include TNX-601, an IND drug candidate designed for daytime
use for the treatment of PTSD, and TNX-801, a potential smallpox-preventing
vaccine.
VBL Therapeutics (NasdaqGM: VBLT) Vascular Biogenics Ltd., operating as VBL
Therapeutics, is a clinical stage biopharmaceutical company focused on the
discovery, development and commercialization of first-in-class treatments for
cancer. The Company’s lead oncology product candidate, ofranergene obadenovec
(VB-111), is a first-in-class, targeted anti-cancer gene-therapy agent that is
positioned to treat a wide range of solid tumors. It is conveniently
administered as an IV infusion once every two months. It has been observed to
be well-tolerated in >200 cancer patients and we have observed its
efficacy signals in an “all comers” Phase 1 trial as well as in three
tumor-specific Phase 2 studies. Ofranergene obadenovec is currently being
studied in a Phase 3 pivotal trial for recurrent Glioblastoma, conducted under
an FDA Special Protocol Assessment (SPA).
New Renewable
Companies Added:
Coherent, Inc. (NasdaqGS:COHR) is one of the world's leading providers of lasers,
laser-based technologies and laser-based system solutions for scientific,
commercial and industrial customers. Our common stock is listed on the Nasdaq
Global Select Market and is part of the Russell 2000 and Standard & Poor's
SmallCap 600 Index. Solar
New Tech Companies Added:
Coherent, Inc. (NasdaqGS:COHR) is one of the world's leading providers of lasers,
laser-based technologies and laser-based system solutions for scientific,
commercial and industrial customers. Our common stock is listed on the Nasdaq
Global Select Market and is part of the Russell 2000 and Standard & Poor's
SmallCap 600 Index. Solar
Eco Science Solutions, Inc. (OTC:ESSI) is a
technology-focused Company based in Hawaii, targeting the multibillion-dollar
health, wellness and alternative medicine industry. From enterprise software,
to consumer applications for daily use, the Company develops technical
solutions that empower enthusiasts in their pursuit and enjoyment of building
eco-friendly businesses and living healthy lifestyles. Eco Science's core
services span localized communications between consumers and business
operators, social networking with like-minded enthusiasts, rich educational
content, e-commerce, and rapid delivery of products, all catering to the
health-and-wellness lifestyle.
New Defense Companies Added:
Coherent, Inc. (NasdaqGS:COHR) is one of the world's leading providers of lasers,
laser-based technologies and laser-based system solutions for scientific,
commercial and industrial customers. Our common stock is listed on the Nasdaq
Global Select Market and is part of the Russell 2000 and Standard & Poor's
SmallCap 600 Index. Defense
Wesco Aircraft Holdings, Inc. (NYSE:WAIR) is the world’s
leading distributor and provider of comprehensive supply chain management
services to the global aerospace industry, based on annual sales. The company’s
services range from traditional distribution to the management of supplier
relationships, quality assurance, kitting, just-in-time delivery and
point-of-use inventory management. The company believes it offers one of the
world’s broadest portfolios of aerospace products, including chemical,
electrical and C-class hardware and comprised of more than 565,000 active SKUs.
Investorideas.com global stock directories are part of the
membership program on the site, accessed either by login and password or
available in PDF format. The directories include stocks trading on the
TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving
retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
About
Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a
meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Sectors we cover include
tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water
stocks, marijuana and hemp stocks, food and beverage (including organic and
LOHAS, wine), defense and security (including biometrics), Latin America,
sports, entertainment, luxury brands and gaming.
Investor Ideas Directories for global investors:
From water stocks to gold and mining stocks,
renewable energy, nanotech, defense, technology, biotech and more – use our
stock directories and access them online 24/7 with login as a member to find
your next big idea!
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution,social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country.
Contact Investorideas.com
800-665-0411
